Apollomics APLM
NASDAQ APLM
$22.28 +1.01 (+4.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

Apollomics (APLM) Short-term Investments (2021 - 2022)

Updated

Apollomics' Short-term Investments came in at $5.76 million for Q4 2023, down 69.8% from $19.07 million a year earlier.

Analysis

Apollomics (APLM) Short-term Investments (2021 - 2022) Analysis & Trends

  • Going back by year, Short-term Investments was $19.07 million in FY2022 (-19.7%) and $23.74 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Apollomics 32.33 Mn -8.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 19.07 Mn
Dec 31, 2021 23.74 Mn
API Access

Apollomics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=APLM&period=max&api_key=YOUR_API_KEY